Haisco
00265365.792.61% ( -1.76 )
Haisco (002653)
Haisco Pharmaceutical Group Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in China. It offers pharmaceutical product...
- Open
- 67.06
- High
- 67.77
- Low
- 65.11
- Prev. Close
- 67.55
- Volume
- 46.45K
- Turnover
- 307.36M
- Avg Price
- 66.17
- Bid/Ask Ratio
- --
- Amplitude
- 3.94%
- 52wk High
- 80.83
- Volume Ratio
- 0.58
- Turnover Ratio
- 0.42%
Haisco Analyst Rating
View MoreForecast & Rating
Jun 5, 2026Price forecast
¥99.0850.67%
Forecast & RatingStrong buy
3analysts
- Strong buy66.67%
- Buy33.33%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jul 23 at 06:32 AM
Nuvectis says China regulator approves ciprocopan for treatment-naive PNH patients
- Yicai · Jul 23 at 06:27 AM
China's Haisco Gets China’s Nod for Rare Blood Disorder Drug
- prnewswire · Jul 23 at 01:10 AM
02:08 ETHaisco's Class 1 Innovative Drug Ciprocopan Succinate Tablets Approved in China, Offering a New Treatment Option for Patients With PNH
- Pharmaceutical Technology · Jun 24 at 03:10 AM
Haisco and Nuvectis sign licensing deal for two drugs
- Unusual Whales · Jun 23 at 08:20 AM
Haisco Enters into Exclusive License Agreement with Nuvectis for Two Drug Candidates in Oncology and Complement Indications
- benzinga_article · Jun 23 at 01:30 AM
Nuvectis Pharma Jumps 20% To 52-Week High — Here's Why NVCT Stock Is Trending
